SCHEMBL3872509

SCHEMBL3872509

N#CC=Cc1ccc(C(F)(F)F)nc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV4 Q9HBA0 1/20 0.44
KDM4E B2RXH2 1/20 0.40
FDPS P14324 1/20 0.39
TRPV1 Q8NER1 1/20 0.38
HTR2A P28223 1/20 0.33
KCNH2 Q12809 1/20 0.33
USP30 Q70CQ3 2/20 0.33
ENPP2 Q13822 1/20 0.33
MLYCD O95822 2/20 0.32
DAO P14920 2/20 0.32
KDM1A O60341 1/20 0.31
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31
P2RX3 P56373 1/20 0.31
P2RX2 Q9UBL9 1/20 0.31
CHRNB2 P17787 1/20 0.31
CHRNA4 P43681 1/20 0.31
MRGPRX4 Q96LA9 1/20 0.30
CCNB2 O95067 1/20 0.30
CDK1 P06493 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19615945 0.77 TRPV4 (0.48) TRPV4TRPV1HTR2AKCNH2DAO
SCHEMBL336320 0.76 TRPV4 (0.52) TRPV4KDM4ETRPV1HTR2AKCNH2
SCHEMBL29417132 0.76 TRPV4 (0.52) TRPV4KDM4ETRPV1HTR2AKCNH2
SCHEMBL18160985 0.74 KDM4E (0.41) KDM4EFDPSKCNH2ENPP2
SCHEMBL6227921 0.74 TRPV4 (0.46) TRPV4KDM4ETRPV1HTR2AKCNH2
SCHEMBL6227922 0.74 TRPV4 (0.46) TRPV4KDM4ETRPV1HTR2AKCNH2
SCHEMBL17966288 0.73 TRPV4 (0.42) TRPV4TRPV1HTR2AKCNH2DAO
SCHEMBL17966289 0.73 TRPV4 (0.42) TRPV4TRPV1HTR2AKCNH2DAO
SCHEMBL7430542 0.73 NFE2L2 (0.44) KDM4EFDPSENPP2
SCHEMBL7430545 0.73 NFE2L2 (0.44) KDM4EFDPSENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101454285-B Oxadiazole derivatives as comt inhibitors PORTELA & CA SA 2012-06-27 CN disclosed
CN-101454285-A Oxadiazole derivatives as comt inhibitors PORTELA & CA SA (PT) 2009-06-10 CN disclosed
EP-2027091-A1 NEW PHARMACEUTICAL COMPOUNDS BIAL - Portela & Ca., S.A. (PT) 2009-02-25 EP disclosed
WO-2007117165-A1 NEW PHARMACEUTICAL COMPOUNDS BIAL - PORTELA & CA, S.A. (PT) 2007-10-18 WO disclosed